Table 1.

CLC-Prediction Results of Tamoxifen from Way2Drug

Pa	Cell Line	Cell Line Full Name	Tissue	Tumor Type
0.811	MCF-7	Breast carcinoma	Breast	Carcinoma
0.573	SK-OV-3	Ovarian carcinoma	Ovarium	Carcinoma
0.469	T47D	Breast carcinoma	Breast	Carcinoma
0.374	HOP-92	Non-small cell lung carcinoma	Lung	Carcinoma
0.333	MCF7S	Breast carcinoma	Breast	Carcinoma
0.332	SNB-75	Glioblastoma	Nervous system	Glioblastoma
0.327	RPMI-8226	Multiple myeloma	Haematopoietic and lymphoid tissue	Myeloma

† Pa, probability of activeness; High Pa values indicate that a substance is highly active in a specific cell line; MCF - 7, Michigan cancer foundation-7; SK-OV-3, ascites-derived ovarian cancer cell line from a 64-year old Caucasian female with an ovarian serous cystadenocarcinoma; T47D, Human breast cancer cells; HOP-92, Hopkins-92; MCF7S, parent MCF-7 subline; SNB-75, Surgical Neurology Branch-75; RPMI-8226, human B cells from a 61-year old male patient with myeloma/plasmacytoma